Art
J-GLOBAL ID:200902255277595206   Reference number:05A0572439

Investigation study team on idiopathic hematopoietic disorder III. Refractory anemia (myelodysplastic syndrome). Studies of small volume combined use therapy (AMA) of 3 drugs of cytarabine, melphalan, and mitoxantrone for myelodysplastic syndrome and old people leukemia, and melphalan high dose therapy and homogeneous mini transplantation for AL amyloidosis.

特発性造血障害に関する調査研究班 III. 不応性貧血(骨髄異形成症候群) 骨髄異形成症候群,高齢者白血病に対するシタラビン,メルファラン,ミトキサントロン3剤併用少量(AMA)療法,ならびにALアミロイドーシスに対するメルファラン大量療法と同種ミニ移植の検討
Author (3):
Material:
Page: 129-132  Publication year: 2005 
JST Material Number: N20051551  Document type: Article
Article type: 短報  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0572439&from=J-GLOBAL&jstjournalNo=N20051551") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for hematologic diseases in general 

Return to Previous Page